3,4-dihydroxyphenylacetic acid and 2-methyltryptoline

3,4-dihydroxyphenylacetic acid has been researched along with 2-methyltryptoline in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, MA; Neafsey, EJ1
Cheng, BY; Christensen, MA; Collins, MA; Hurley-Gius, D; Hurley-Gius, K; Neafsey, EJ; Pronger, DA; Ung-Chhun, NA1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 2-methyltryptoline

ArticleYear
Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism?
    Neuroscience letters, 1985, Apr-09, Volume: 55, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Aotus trivirgatus; Carbolines; Caudate Nucleus; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Indoles; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Serotonin; Substantia Nigra

1985
Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.
    Advances in neurology, 1987, Volume: 45

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Aotus trivirgatus; Brain; Carbolines; Dopamine; Homovanillic Acid; Mice; Mice, Inbred C57BL; Parkinson Disease, Secondary; Pyridines; Structure-Activity Relationship

1987